glutathione and parkinson's disease 2019 S-transferase: A keystone in pathogenesis therapy Frontiers | Early diagnosis of
Description
doi: 10.1111/imr.13326 8 NankabirwaVTumwineJKMugabaPMTylleskrTSommerfeltH
While some patients may opt to start with education, behavior modification, or physical therapy alone, other patients will benefit from concomitant oral and/or intravesical treatments
Humphreys et al
[DOI] [PubMed] [Google Scholar] 3.Fosgerau K, Hoffmann T: Peptide therapeutics: Current status and future directions
